DNDi’s FACT Project: A New Kind of Partnership to Deliver New Products.

Abstract

This presentation describes the Fixed-Dose ACT Project for Malaria, which led to the development of the new antimalarial formulations ASAQ (artesunate-amodiaquine) and ASMQ (artesunate-mefloquine): the reasons why these formulations were needed, the partnership of public and private sector organizations that were involved in their development, the cost and sources of funding, and (briefly) the outlook for implementation of the new therapies.

Citation

Kiechel, J.R. DNDi’s FACT Project: A New Kind of Partnership to Deliver New Products. (2008)

DNDi’s FACT Project: A New Kind of Partnership to Deliver New Products.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.